Clinical trial
Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients
NCT00229749 · Sarepta Therapeutics, Inc., Industry · Terminated
Key facts
| NCT number | NCT00229749 |
|---|---|
| Title | Study of AVI-4065 in Healthy Volunteers and Chronic Active HCV Patients |
| Official title | Exploratory Study of AVI-4065 Injection to Design Therapeutic Dosing for Chronic Active HCV Patients |
| Lead sponsor | Sarepta Therapeutics, Inc., Industry |
| Status | Terminated |
| Phase | Phase 1/Phase 2 |
| Study type | Interventional |
| Conditions | Hepatitis C |
| Intervention type | Drug |
| Interventions | AVI-4065 Injection |
| Enrollment | 80 |
| Start date | Sep 1, 2005 |
| Primary completion | Oct 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Sep 30, 2005 |
| Last update posted | Apr 10, 2008 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: